PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.81%
Revenue growth below 50% of CRWD's 5.94%. Michael Burry would check for competitive disadvantage risks.
90.99%
Cost growth above 1.5x CRWD's 7.31%. Michael Burry would check for structural cost disadvantages.
-13.92%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
-14.61%
Both companies show margin pressure. Martin Whitman would check industry conditions.
27.60%
R&D growth above 1.5x CRWD's 3.75%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.71%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
8.78%
Total costs growth above 1.5x CRWD's 4.38%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
16.77%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-4.77%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
93.10%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
-8.24%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-8.98%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-501.97%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-97.32%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-97.34%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-97.27%
Both companies reducing tax expense. Martin Whitman would check patterns.
-97.35%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-97.37%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-97.83%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-97.73%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
0.82%
Share count reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.
0.14%
Diluted share reduction exceeding 1.5x CRWD's 0.59%. David Dodd would verify capital allocation.